Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

Hoffmann-La Roche (1)

M.D. Anderson Cancer Center (1)

Collaborator

Gilead Sciences (1)

Intervention

axitinib (1)

entrectinib (1)

sacituzumab govitecan (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

salivary gland cancers

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting

Gland
Salivary Gland Cancers

Sacituzumab Govitecan

Houston, Texas

M D Anderson Cancer Center

May 22, 2023

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting

Breast Cancer
+15 more

Entrectinib

Goodyear, Arizona
+146 more

Aug 24, 2022

Salivary Gland Cancers Trial in Milan (Axitinib)

Completed

Salivary Gland Cancers

Axitinib

Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

Aug 28, 2019